US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report

BACKGROUND: Current American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines and European Society of Cardiology guidelines recommend antiarrhythmic drugs (AADs) for maintenance of sinus rhythm in patients with atrial fibrillation. We assessed the concordance between...

Descripción completa

Detalles Bibliográficos
Autores principales: Tardos, Jonathan G., Ronk, Christopher J., Patel, Miraj Y., Koren, Andrew, Kim, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174194/
https://www.ncbi.nlm.nih.gov/pubmed/33686868
http://dx.doi.org/10.1161/JAHA.120.016792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174194/
https://www.ncbi.nlm.nih.gov/pubmed/33686868
http://dx.doi.org/10.1161/JAHA.120.016792

Ejemplares similares